HDSA RESEARCH WEBINAR: All You Need To Know About PROOF-HD

preview_player
Показать описание
On Wednesday, September 7, 2022, Dr. Michael Hayden, CEO of Prilenia, along with Drs. Andy Feigin and Sandra Kostyk, provided an overview and insights into the progress of PROOF-HD, a global, Phase 3 study evaluating pridopidine for the treatment of #HuntingtonsDisease.

#LetsTalkAboutHD #HDSAFamily
Рекомендации по теме
Комментарии
Автор

Is the drug available now via compassionate use/expanded access?

Jim-ujon
Автор

Is there any plan to give this drug if successful to middle stage or end stage HD patients please

bernadetteoleary